Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

125
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
125
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
Aging01:26

Aging

59
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility.

Science advances·2025
Same author

Maternal Diet Quality and BMI as Predictors of Human Milk C-Reactive Protein Concentrations.

The Journal of nutrition·2025
Same author

The state of the science on the health benefits of blueberries: a perspective.

Frontiers in nutrition·2024
Same author

Reply to Lee, S.Y. Comment on "Krikorian et al. Early Intervention in Cognitive Aging with Strawberry Supplementation. <i>Nutrients</i> 2023, <i>15</i>, 4431".

Nutrients·2024
Same author

Infant Obesity Prevention Programs for Underrepresented Mothers in a Home Visiting Program: A Qualitative and Community-Engaged Needs Assessment.

Community health equity research & policy·2023
Same author

Detecting mild cognitive impairment remotely with the modified memory impairment screen by telephone.

Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition·2023

Related Experiment Video

Updated: Jul 12, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K

Early Intervention in Cognitive Aging with Strawberry Supplementation.

Robert Krikorian1, Marcelle D Shidler1, Suzanne S Summer2

  • 1Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA.

Nutrients
|October 28, 2023
PubMed
Summary

Daily strawberry powder intake in middle-aged adults with insulin resistance improved memory and reduced depressive symptoms, suggesting a role in dementia risk reduction. Further research is needed for metabolic benefits.

Keywords:
aginganthocyaninscognitiondementia risk reductioninsulin resistancestrawberries

More Related Videos

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

4.7K
Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

796

Related Experiment Videos

Last Updated: Jul 12, 2025

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.4K
Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

4.7K
Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

796

Area of Science:

  • Neuroscience
  • Public Health
  • Nutritional Science

Background:

  • Late-life dementia, including Alzheimer's disease (AD), poses a significant public health challenge with no effective treatments.
  • Neurodegenerative disorders develop over decades, with risk factors like insulin resistance emerging in midlife.
  • Dietary interventions, such as berry consumption, may influence metabolism and cognition, potentially mitigating dementia risk.

Purpose of the Study:

  • To investigate the effects of daily whole-fruit strawberry powder supplementation on cognitive function and metabolic measures in middle-aged adults with insulin resistance and subjective cognitive decline.

Main Methods:

  • A 12-week controlled trial involving overweight middle-aged men and women with insulin resistance and subjective cognitive decline.
  • Participants received daily whole-fruit strawberry powder, with diet records confirming adherence to berry abstinence.
  • Evaluated outcomes included memory interference, depressive symptoms, executive function, and metabolic markers.

Main Results:

  • Strawberry supplementation significantly diminished memory interference (p = 0.02) and reduced depressive symptoms (p = 0.04).
  • Observed cognitive benefits suggest improvements in executive ability.
  • No significant effects on metabolic measures were detected, potentially due to sample size, intervention duration, or anthocyanin dosage.

Conclusions:

  • Strawberry supplementation introduced in midlife may play a role in reducing dementia risk by improving cognitive function and mood.
  • Further research with extended intervention periods, larger cohorts, and varied dosages is necessary to fully elucidate the cognitive and metabolic benefits of strawberry intake in aging populations.